What does CUSIP 14888U101 represent in this 13F holders report?

CUSIP 14888U101 is the security identifier for CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock in Q2 2017?

68 institutional investors reported CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock for Q2 2017. Use the holders table for investor-level position and value details.

CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX)

CUSIP: 14888U101

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class: Equity / Common Stock
Shares outstanding: 123,180,519
Total 13F shares: 33,946,250
Share change: +8,695,965
Total reported value: $93,689,694
Put/Call ratio: 8.8%
Price per share: $2.76
Number of holders: 68
Value change: +$24,746,037
Number of buys: 43
Number of sells: 18

Quarterly Holders Quick Answers

What is CUSIP 14888U101?
CUSIP 14888U101 identifies CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2017
Previous quarter: Q1 2017

Recent filing periods for CUSIP 14888U101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Broadfin Capital, LLC	13F	Company	6.7%	8,200,000	$15,990,000	—	31 Mar 2017	13F
BAKER BROS. ADVISORS LP	13F	Company	4.1%	5,102,153	$9,949,000	—	31 Mar 2017	13F
Avoro Capital Advisors LLC	13F	Company	3.1%	3,804,745	$7,419,000	—	31 Mar 2017	13F
VANGUARD GROUP INC	13F	Company	2.4%	3,007,935	$5,865,000	—	31 Mar 2017	13F
Point72 Asset Management, L.P.	13F	Company	0.71%	877,266	$1,711,000	—	31 Mar 2017	13F
S.c.a. Candriam	13F	Individual	0.49%	600,000	$1,170,000	—	31 Mar 2017	13F
BlackRock Finance, Inc.	13F	Company	0.45%	552,803	$1,077,000	—	31 Mar 2017	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.38%	462,677	$902,000	—	31 Mar 2017	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.31%	382,400	$746,000	—	31 Mar 2017	13F
David M. Knott	13F	Individual	0.23%	284,350	$554,000	—	31 Mar 2017	13F
CORRADO ADVISORS, LLC	13F	Company	0.2%	251,025	$489,000	—	31 Mar 2017	13F
KENNEDY CAPITAL MANAGEMENT LLC	13F	Company	0.19%	230,500	$449,000	—	31 Mar 2017	13F
TANAKA CAPITAL MANAGEMENT INC	13F	Company	0.17%	213,492	$416,000	—	31 Mar 2017	13F
ROYAL BANK OF CANADA	13F	Company	0.13%	165,000	$322,000	—	31 Mar 2017	13F
DEUTSCHE BANK AG\	13F	Company	0.11%	136,788	$266,000	—	31 Mar 2017	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.11%	135,872	$265,000	—	31 Mar 2017	13F
NORTHERN TRUST CORP	13F	Company	0.09%	111,328	$217,000	—	31 Mar 2017	13F
JPMORGAN CHASE & CO	13F	Company	0.06%	79,470	$155,000	—	31 Mar 2017	13F
Bank of New York Mellon Corp	13F	Company	0.06%	69,175	$135,000	—	31 Mar 2017	13F
Weiss Multi-Strategy Advisers LLC	13F	Company	0.06%	68,000	$133,000	—	31 Mar 2017	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.05%	60,067	$117,000	—	31 Mar 2017	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.05%	58,940	$115,000	—	31 Mar 2017	13F
A.R.T. Advisors, LLC	13F	Company	0.04%	51,207	$99,000	—	31 Mar 2017	13F
STATE STREET CORP	13F	Company	0.04%	45,300	$88,000	—	31 Mar 2017	13F
AGRAN LIBBIE	13F	Company	0.04%	44,000	$86,000	—	31 Mar 2017	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.03%	41,332	$81,000	—	31 Mar 2017	13F
MORGAN STANLEY	13F	Company	0.02%	26,345	$52,000	—	31 Mar 2017	13F
GUGGENHEIM CAPITAL LLC	13F	Company	0.02%	24,984	$49,000	—	31 Mar 2017	13F
Commonwealth Equity Services, Inc	13F	Company	0.02%	24,090	$47,000	—	31 Mar 2017	13F
HBK Sorce Advisory LLC	13F	Company	0.02%	22,109	$43,000	—	31 Mar 2017	13F
Malaga Cove Capital, LLC	13F	Company	0.02%	20,000	$38,000	—	31 Mar 2017	13F
ProVise Management Group, LLC	13F	Company	0.02%	19,000	$37,000	—	31 Mar 2017	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.02%	18,654	$36,000	—	31 Mar 2017	13F
CREDIT SUISSE AG/	13F	Company	0.01%	16,000	$31,000	—	31 Mar 2017	13F
Raymond James Financial Services Advisors, Inc.	13F	Company	0.01%	15,500	$30,000	—	31 Mar 2017	13F
TWO SIGMA SECURITIES, LLC	13F	Company	0.01%	12,863	$25,000	—	31 Mar 2017	13F
Cubist Systematic Strategies, LLC	13F	Company	0.01%	11,500	$22,000	—	31 Mar 2017	13F
Creative Planning	13F	Company	0.01%	10,681	$21,000	—	31 Mar 2017	13F
Acrospire Investment Management LLC	13F	Company	0.01%	9,768	$19,000	—	31 Mar 2017	13F
Segantii Capital Management Ltd	13F	Company	0.01%	6,700	$13,000	—	31 Mar 2017	13F
Cutler Group LLC / CA	13F	Company	0%	5,646	$11,000	—	31 Mar 2017	13F
CITIGROUP INC	13F	Company	0%	4,088	$8,000	—	31 Mar 2017	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0%	3,218	$6,000	—	31 Mar 2017	13F
Vantage Investment Advisors, LLC	13F	Company	0%	3,000	$6,000	—	31 Mar 2017	13F
Geneos Wealth Management Inc.	13F	Company	0%	2,500	$4,000	—	31 Mar 2017	13F
LADENBURG THALMANN FINANCIAL SERVICES INC.	13F	Company	0%	2,000	$4,000	—	31 Mar 2017	13F
ADVANTAGE INVESTMENT MANAGEMENT, LLC	13F	Company	0%	1,500	$3,000	—	31 Mar 2017	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	1,459	$3,000	—	31 Mar 2017	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	1,001	$2,000	—	31 Mar 2017	13F
IFP Advisors, Inc	13F	Company	0%	1,000	$2,000	—	31 Mar 2017	13F

Institutional Holders of CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) as of Q2 2017

As of 30 Jun 2017, CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) was held by 68 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 33,946,250 shares. The largest 10 holders included Broadfin Capital, LLC, BAKER BROS. ADVISORS LP, venBio Select Advisor LLC, BlackRock Inc., VANGUARD GROUP INC, JPMORGAN CHASE & CO, STATE STREET CORP, KENNEDY CAPITAL MANAGEMENT, INC., RENAISSANCE TECHNOLOGIES LLC, and NORTHERN TRUST CORP. This page lists 68 institutional shareholders reporting positions in this security for the Q2 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2017 vs Q1 2017 Across Filers

Q1 2017 holders

Q2 2017 holders

Holder diff

Investor	Q1 2017 Shares	Q2 2017 Shares	Share Diff	Share Chg %	Q1 2017 Value $	Q2 2017 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.